Specific mTOR inhibitors in the treatment of X-linked adrenoleukodystrophy

MA39496AUndetermined Publication Date: 2016-03-24CENT DE INVESTIGACION BIOMEDICA & RED CIBER +2

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA39496
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-09-19
Filing Date: 2015-09-21
Publication Date: 2016-03-24

Application Information

Patent Timeline

19 Sep 2014

Priority

21 Sep 2015

Application

MA39496

24 Mar 2016

Publication

MA39496A

IPC: A61K31/436; A61K45/06

CPC: A61K31/05; A61K31/132; A61K31/138; A61K31/194; A61K31/277; A61K31/341; A61K31/343; A61K31/436

Inventors: KNECHT ROBERTO Erwin; PUJOL ONOFRE Aurora

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The invention relates to novel uses of specific mTOR inhibitors as a drug, particularly for the treatment of x-linked adrenoleukodystrophy (x-ALD). The invention also relates to a method for identifying a compound potentially useful for the treatment and / or prevention of x-ALD.

Need to check novelty before this filing date? Find Prior Art